Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...
European real-world data show strong Solaris SX™ performance in PAD, complementing findings from the DEScover sirolimus-eluting program The twelve-month results from this multicenter study show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback